Skip to main content
Clinical Trials/NCT06040827
NCT06040827RecruitingNot Applicable

A Multicenter, Postmarket Surveillance Study of Subjects With the Canary canturioTM te Tibial Extension

Canary Medical7 sites in 1 country626 target enrollmentStarted: September 12, 2023Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Sponsor
Enrollment
626
Locations
7
Primary Endpoint
Safety - Adverse Events

Study Overview

Brief Summary

The objectives of this prospective observational cohort study are to evaluate the safety, reliability, reproducibility, and accuracy of the Canary canturioTM te post-TKA.

Detailed Description

Group 1 (Test): Zimmer Persona® Personalized Knee System with Canary canturioTM (CTE) tibial extension Group 2 (Control): Zimmer Persona® Personalized Knee System with 14 mm +30 mm stem extension Safety Endpoint The nature, severity, and frequency of safety risks in subjects with the Canary canturioTM te will be compared to those subjects with the legally marketed Zimmer Persona® Personalized Knee System with 14 mm x +30 mm stem extension within 5 years post-TKA.

The safety endpoint is the percentage of patients that meet any of the following criteria within 5 years post-TKA:

  • Revision (tibia only)
  • Aseptic loosening
  • Instability (or unrecognized septic loosening)
  • Intra-operative fracture of bone or device
  • Post-operative fracture of bone or device
  • Radiologic changes including:
  • Lytic lines (radiolucency greater than 2 mm in 2 or more zones)
  • Focal lysis(progressive osteolytic lesion)
  • Osteolysis (3mm in more than 1 zone)
  • Device fracture or failure (tibia only)
  • Cortical thickening or periosteal reactions

Secondary Endpoints

The secondary endpoints (for 5 years post-TKA) are:

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Safety - Adverse Events

Time Frame: 5 years post TKA

The nature, severity, and frequency of safety risks (Adverse Events) in subjects with the Canary canturioTM te will be compared to those subjects with the legally marketed Zimmer Persona® Personalized Knee System with 14 mm x +30 mm stem extension within 5 years post-TKA.

Secondary Outcomes

  • Percent of days with step-count data transmitted(5 years post TKA)
  • Percent of days with qualified gait cycles >0 (applicable for walking speed meter/second, stride length meter, tibia ROM, functional knee ROM and cadence)(5 years post TKA)
  • Knee Injury and Osteoarthritis Outcome Score (KOOS - JR)(5 years post TKA)
  • Numeric Pain Rating Scale (NPRS)(5 years post TKA)
  • Percent of days with one or more gait bouts triggered and transmitted(5 years post TKA)
  • Percent of days with step-count data transmitted and qualified gait cycles >0 (applicable for distance in meters)(5 years post TKA)
  • Quality-of-life- EQ-5D-5L(5 years post TKA)

Investigators

Sponsor
Canary Medical
Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (7)

Loading locations...

Similar Trials